{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T05:57:44Z","timestamp":1709272664984},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.carrev.2024.02.006","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T07:09:16Z","timestamp":1707721756000},"update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of hyperuricemia on 5-year clinical outcomes following percutaneous transluminal angioplasty"],"prefix":"10.1016","author":[{"given":"Woo Jin","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Joon","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Woon","family":"Rha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soohyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Jin","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ah","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Kyeong","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Ung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Joo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Geol","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2024.02.006_bb0005","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"issue":"2017","key":"10.1016\/j.carrev.2024.02.006_bb0010","first-page":"e686","article-title":"AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.02.006_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2024.02.006_bb0020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.carrev.2024.02.006_bb0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.carrev.2024.02.006_bb0030","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","article-title":"New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity","volume":"319","author":"Furuhashi","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.carrev.2024.02.006_bb0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.HYP.0000150784.92944.9a","article-title":"Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence","volume":"45","author":"Sundstr\u00f6m","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.carrev.2024.02.006_bb0040","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2024.02.006_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.carrev.2024.02.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020076","article-title":"Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis","volume":"2","author":"Wheeler","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.carrev.2024.02.006_bb0055","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","article-title":"Uric acid and inflammatory markers","volume":"27","author":"Ruggiero","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.carrev.2024.02.006_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.mnh.0000199010.33929.7f","article-title":"Hormonal and cytokine effects of uric acid","volume":"15","author":"S\u00e1nchez-Lozada","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.carrev.2024.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.amjcard.2005.07.068","article-title":"Status of endothelial dependent vasodilation in patients with hyperuricemia","volume":"96","author":"Kato","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.carrev.2024.02.006_bb0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","article-title":"Allopurinol improves endothelial dysfunction in chronic heart failure","volume":"106","author":"Farquharson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.02.006_bb0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000087713","article-title":"Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter","volume":"25","author":"Kang","year":"2005","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.carrev.2024.02.006_bb0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.atherosclerosis.2006.12.029","article-title":"Association between serum uric acid level and peripheral arterial disease","volume":"196","author":"Shankar","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2024.02.006_bb0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5551\/jat.37010","article-title":"Association of serum uric acid levels with leg ischemia in patients with peripheral arterial disease after treatment","volume":"24","author":"Sotoda","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.carrev.2024.02.006_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9150(03)00093-5","article-title":"Serum uric acid in hypertensive patients with and without peripheral arterial disease","volume":"168","author":"Langlois","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2024.02.006_bb0095","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1464-5491.2004.01239.x","article-title":"Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes","volume":"21","author":"Tseng","year":"2004","journal-title":"Diabet. Med."},{"key":"10.1016\/j.carrev.2024.02.006_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186220","article-title":"Prevalence of peripheral artery disease (PAD) and factors associated: an epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study","volume":"12","author":"Cornejo Del R\u00edo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.carrev.2024.02.006_bb0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.avsg.2021.09.030","article-title":"C-reactive protein, free fatty acid, and uric acid as predictors of adverse events after endovascular revascularization of arterial femoropopliteal occlusion lesions","volume":"81","author":"Di","year":"2022","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.carrev.2024.02.006_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.HYP.0000254480.64564.b6","article-title":"Hyperuricemia and incidence of hypertension among men without metabolic syndrome","volume":"49","author":"Krishnan","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.carrev.2024.02.006_bb0115","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2174\/1381612811319130011","article-title":"Chronic hyperuricemia, uric acid deposit and cardiovascular risk","volume":"19","author":"Grassi","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.carrev.2024.02.006_bb0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.carrev.2024.02.006_bb0125","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.56786\/PHWR.2022.15.45.2808","article-title":"Trends in prevalence of diabetes, 2011-2020","volume":"15","year":"2022","journal-title":"Public Health Weekly Report"},{"key":"10.1016\/j.carrev.2024.02.006_bb0130","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2011-201254","article-title":"Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study","volume":"72","author":"Trifir\u00f2","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.carrev.2024.02.006_bb0135","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.carrev.2024.02.006_bb0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.semnephrol.2011.08.004","article-title":"The epidemiology of uric acid and fructose","volume":"31","author":"Rho","year":"2011","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.carrev.2024.02.006_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","volume":"80","author":"Borghi","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.carrev.2024.02.006_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/1440-1681.12911","article-title":"Hyperuricaemia and development of type 2 diabetes mellitus in Asian population","volume":"45","author":"Choi","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.carrev.2024.02.006_bb0155","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.carrev.2024.02.006_bb0160","first-page":"370","article-title":"How to define obesity?","volume":"17","author":"Pan","year":"2008","journal-title":"Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations, Asia Pac J Clin Nutr"},{"key":"10.1016\/j.carrev.2024.02.006_bb0165","article-title":"Long-term outcomes of peripheral arterial disease patients with significant coronary artery disease undergoing percutaneous coronary intervention","volume":"16","author":"Choi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.carrev.2024.02.006_bb0170","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurheartj\/ehl441","article-title":"Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study","volume":"28","author":"Tzoulaki","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.carrev.2024.02.006_bb0175","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1161\/CIRCRESAHA.121.318258","article-title":"Contemporary medical management of peripheral artery disease","volume":"128","author":"Bonaca","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.carrev.2024.02.006_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jare.2016.11.004","article-title":"Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review","volume":"8","author":"Sharaf El Din","year":"2017","journal-title":"J. Adv. Res."}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T01:18:08Z","timestamp":1708219088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":36,"alternative-id":["S1553838924000459"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.02.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of hyperuricemia on 5-year clinical outcomes following percutaneous transluminal angioplasty","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}